Delivery Order SPE2DE24D0013-SPE2D625F9ZS2
- Not listed
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on August 11, 2025, for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This delivery order, with an ultimate completion date of August 18, 2025, carries no set-aside designation and represents a focused procurement of molecular diagnostic products or services from the Sunnyvale, California-based manufacturer. The award likely falls under...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Department of Defense Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This delivery order, issued on August 7, 2025, with an ultimate completion date of August 14, 2025, represents a continuation of Cepheid's established role as a primary supplier of advanced diagnostic systems and test kits to federal healthcare entities. The...
- The U.S. Department of Defense awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, under contract number 4569009257 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, which carries no set-aside designation, is set to conclude by August 12, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order falls under one of Cepheid's two significant...
- The U.S. Department of Defense Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, influenza, and respiratory syncytial virus (RSV) testing solutions. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation and represents performance work in Sunnyvale, California. The delivery order is associated with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9ZS2Delivery Order
The Defense Department's Medical Supply Chain awarded an $14.55K firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The contract, with an ultimate completion date of August 8, 2025, represents a delivery order against Cepheid's existing federal contract vehicles and carries no set-aside designation. Performance will be executed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a specialized manufacturer of molecular diagnostic systems and test kits with extensive experience serving federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company holds multiple Indefinite Delivery Vehicle contracts with the VA, including a $32.8M single-award IDV with Veterans Integrated Service Network 6 and a $2.5M IDV with Veterans Integrated Service Network 21, both providing PCR testing reagents and assays for infectious disease detection. This delivery order aligns with Cepheid's core business of supplying advanced diagnostic equipment and reagents for detecting respiratory and infectious diseases across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 8/1/25 |